Psoriasis is a chronic, multisystem disease which can have a significant negative impact on the quality of life of patients. Effective treatment is very important to prevent or reduce the progression of psoriasis into articular and vascular involvement. Conventional systemic therapy has long been the mainstay of treatment for moderate-to-severe psoriasis. The emerging of targeted biologic therapy offers several advantages, including simpler dosing and better efficacy with favourable safety and tolerability. Under diagnosis, lack of access towards newer biological therapies, inadequate treatment, and failure to improve difficult-to-treat areas are amongst the unmet needs of psoriatic patients in developing countries. These issues will need to be addressed comprehensively to improve the patients’ quality of life.
Keywords: psoriasis, unmet needs, developing countries